HCP portals typically have mixed reputations amongst their end users but, when executed correctly, they can bring significant benefits and create value for HCPs, patients, and pharma teams.

NICE has recommended moving Novartis’ Kisqali (ribociclib) from interim funding arrangements to regular NHS reimbursement for certain previously treated breast cancer patients. In the final ...

Today we are looking at HashiCorp (NASDAQ:HCP) and the best and worst performers in the software development industry. Let’s dig into the relative performance of Bandwidth (NASDAQ:BAND ...

After hours: November 11 at 4:42 PM EST ...

Another point of concern for BofA Securities is the potential impact of the upcoming Kisqali patent litigation outcome. Should the decision fall unfavorably for Novartis, it could lead to a ...

HCP Plastene Bulkpack Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 183.61 Crore) operating in Packaging sector. HCP Plastene Bulkpack Ltd. key ...